Search Results - "Trepel, JB"
-
1
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy
Published in Leukemia (01-10-2001)“…The Bcr-Abl fusion protein drives leukemogenesis and can render leukemia cells resistant to conventional chemotherapy. Geldanamycin (GA), a drug which…”
Get full text
Journal Article -
2
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer
Published in International journal of cancer (01-10-2016)“…The eukaryotic translation initiation factor 4E (eIF4E) is a potent oncogene that is found to be dysregulated in 30% of human cancer, including colorectal…”
Get full text
Journal Article -
3
Abstract P2-11-10: Epigenetic immune modulation by entinostat in breast cancer: Correlative analysis of ENCORE 301 trial
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Background: Entinostat, a class I HDAC inhibitor (HDACi), has shown promising activity in ENCORE 301, a randomized, placebo-controlled, phase II trial of…”
Get full text
Journal Article -
4
Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma
Published in Journal of clinical oncology (10-06-2005)“…The objective of this study was to define the maximum-tolerated dose (MTD), the recommended phase II dose, the dose-limiting toxicity, and determine the…”
Get full text
Journal Article -
5
Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275
Published in Cancer research (Chicago, Ill.) (01-01-2004)“…Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation for cancer therapy. Because HDAC modulates chromatin structure and gene expression,…”
Get full text
Journal Article -
6
MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays
Published in Cell reports methods (24-01-2022)“…Extracellular vesicles (EVs) of various types are released or shed from all cells. EVs carry proteins and contain additional protein and nucleic acid cargo…”
Get full text
Journal Article -
7
Impact of extracellular folate levels on global gene expression
Published in Molecular pharmacology (01-12-2001)“…Methylation of DNA is associated with gene silencing. DNA methylation uses S-adenosylmethionine (SAM) as the methyl donor and the formation of SAM requires a…”
Get more information
Journal Article -
8
Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Published in Molecular cancer therapeutics (01-12-2004)“…Folates are essential for cell survival and are required for numerous biochemical processes. The human α isoform folate receptor (αhFR) has a very high…”
Get full text
Journal Article -
9
Abrogation of p21 Expression by Flavopiridol Enhances Depsipeptide-Mediated Apoptosis in Malignant Pleural Mesothelioma Cells
Published in Clinical cancer research (01-03-2004)“…Purpose: Recent insights regarding the pathogenesis of malignant pleural mesothelioma (MPM) provide new opportunities for targeted molecular therapies for this…”
Get full text
Journal Article -
10
Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin
Published in Blood (01-08-2002)“…In epithelial cells β-catenin plays a critical role as a component of the cell-cell adhesion apparatus and as a coactivator of the TCF/LEF (T-cell…”
Get full text
Journal Article -
11
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
Published in Carcinogenesis (New York) (01-03-2003)“…The effects of lovastatin, a potent inhibitor of HMG CoA reductase, on experimental mammary and prostate oncogenesis, were studied in vitro and in vivo…”
Get full text
Journal Article -
12
DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation
Published in Cancer research (Chicago, Ill.) (15-04-2008)“…In a previous genomic analysis, using somatic methyltransferase (DNMT) knockout cells, we showed that hypomethylation decreased the expression of as many genes…”
Get full text
Journal Article -
13
DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells
Published in British journal of cancer (24-02-2003)“…The fluorinated benzothiazole analogue 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is a novel agent with potent and selective…”
Get full text
Journal Article -
14
Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
Published in Molecular cancer therapeutics (01-06-2004)“…Aminoflavone (4H-1-benzopyran-4-one, 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl; NSC 686288) demonstrates differential antiproliferative activity…”
Get full text
Journal Article -
15
A phase II study of perifosine in androgen independent prostate cancer
Published in Cancer biology & therapy (01-10-2005)“…OBJECTIVES: Perifosine is an alkylphospholipid that has exhibited broad antineoplastic activity in preclinical studies. The primary objective of this study was…”
Get full text
Journal Article -
16
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling
Published in Oncogene (11-10-2001)“…Androgen deprivation therapy for advanced prostate cancer is often effective, but not curative. Molecular pathways mediating the therapeutic response and those…”
Get full text
Journal Article -
17
Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole
Published in Molecular pharmacology (01-01-2002)“…2-(4-Amino-3-methylphenyl) benzothiazole (NSC 674495; DF 203) demonstrates drug uptake and metabolism by tumor cells sensitive to the antiproliferative…”
Get more information
Journal Article -
18
MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type II receptor expression in human breast cancer cells
Published in Cancer research (Chicago, Ill.) (01-02-2001)“…Transcriptional repression of the transforming growth factor (TGF)-1P type II receptor (TPRII) gene appears to be a major mechanism to inactivate TGF-beta…”
Get full text
Journal Article -
19
Protease inhibitor-induced apoptosis : accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition
Published in Leukemia (01-07-2000)“…Inhibitors of proteases are currently emerging as a potential anti-cancer modality. Nonselective protease inhibitors are cytotoxic to leukemia and cancer cell…”
Get full text
Journal Article -
20
Sequential 5-Aza 2′-deoxycytidine depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells
Published in Oncogene (31-03-2005)“…cDNA arrays were used to examine gene induction in CALU-6 and H460 lung cancer cells mediated by sequential 5-aza 2'-deoxycytidine (DAC)/depsipeptide FK228…”
Get full text
Journal Article